Cargando…
Can Reverse T3 Assay Be Employed to Guide T4 vs. T4/T3 Therapy in Hypothyroidism?
Autores principales: | Gomes-Lima, Cristiane, Wartofsky, Leonard, Burman, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917573/ https://www.ncbi.nlm.nih.gov/pubmed/31920970 http://dx.doi.org/10.3389/fendo.2019.00856 |
Ejemplares similares
-
Editorial: Levothyroxine Therapy in Patients With Hypothyroidism
por: Antonelli, Alessandro, et al.
Publicado: (2021) -
A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology—A Pilot Cohort Study
por: Gomes-Lima, Cristiane J., et al.
Publicado: (2020) -
Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?
por: Gomes-Lima, Cristiane J., et al.
Publicado: (2021) -
30 mCi exploratory scan for two-step dosimetric (131)I therapy in differentiated thyroid cancer patients: A novel approach and case report
por: Wu, Di, et al.
Publicado: (2020) -
Predicting Optimal Combination LT4 + LT3 Therapy for Hypothyroidism Based on Residual Thyroid Function
por: DiStefano, Joseph, et al.
Publicado: (2019)